Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural Life's EBIT per Share for the
six
months ended in Sep. 2025 was $-0.22.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $36.55.
During the past 12 months, the average EBIT per Share Growth Rate of Bon Natural Life was -102.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Bon Natural Life's EBIT per Share or its related term are showing as below:
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Bon Natural Life was 115.60% per year. The lowest was -54.70% per year. And the median was 21.25% per year.
BON's 3-Year EBIT Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.1 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Bon Natural Life (NAS:BON) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Bon Natural Life EBIT per Share Related Terms
Bon Natural Life EBIT per Share Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $36.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a EBIT per Share of $36.55 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bon Natural Life and its competitors. According to the industry distribution chart, Bon Natural Life ranks #999999 out of 1337 companies in the Chemicals industry.
Is Bon Natural Life's EBIT per Share too high?
Bon Natural Life's current EBIT per Share is $36.55. Based on the distribution chart, Bon Natural Life ranks #999999 out of 1337 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's EBIT per Share compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #999999 out of 1337 companies for EBIT per Share. This places Bon Natural Life in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bon Natural Life and its competitors. Bon Natural Life's current EBIT per Share is $36.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.14 — trading 50% above its estimated fair value. The current EBIT per Share is $36.55. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Bon Natural Life (BON), the current EBIT per Share is $36.55 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 50% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
EBIT per Share: $36.55
GF Value™: $0.76 vs. price of $1.14 (50% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
